“syndax-pharmaceuticals” Archives

in
Entry Author Date Location
East Coast Biotech Roundup: Ribon, Syndax, Aldeyra & More 03/03/16 Boston
Syndax Cuts Price But Bags $53M in Second IPO Try 03/02/16 Boston
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
East Coast Biotech Roundup: StartUp Health, Constellation, Highline & More 08/28/15 New York
New CEO and $80M Later, Syndax Looks Prepped for Second IPO Try 08/24/15 Boston
Syndax Pharmaceuticals Garners $80,000,000 New Financing 08/24/15 Boston
East Coast Biotech Roundup: Emulate, Pulmatrix, Synergy & More 06/19/15 New York
Syndax Pharmaceuticals Obtains $23,961,064 New Financing Round 06/16/15 Boston
East Coast Biotech Roundup: NY Bio Fund, Sarepta, ZappRx, & More 04/03/15 Boston
Pivoting From IPO, Syndax Inks Combo Trial Deal With Merck 03/31/15 Boston
East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More 02/20/15 Boston
Syndax CEO Says an Immuno-Oncology Thing Happened on the Way to IPO 02/17/15 Boston
East Coast Biotech Roundup: Alnylam, Stock Offerings, Curis, & More 01/23/15 Boston
East Coast Biotech Roundup: Pre-J.P. Morgan Preening Edition 01/09/15 Boston
Syndax Pharmaceuticals Garners $4,947,480 New Round 09/22/14 Boston
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
East Coast Biotech Roundup: Neurophage, Boston Biotech, Insmed, & More 03/28/14 Boston
Syndax Plots $69M IPO For Cancer Drug’s Stretch Run 03/27/14 Boston
East Coast Life Sciences Roundup: Genocea, Biogen, OvaScience, & More 09/13/13 Boston
East Coast Life Sciences Roundup: Aileron, Enzymatics, Acton, & More 09/06/13 Boston
East Coast Life Sciences Roundup: Syndax, Enteris, Invivo, & More 08/30/13 Boston
Syndax Pockets $26.6M For Final Stage Push With Cancer Drug 08/27/13 Boston
Syndax Pharmaceuticals Lands $26,600,000 Series B Financing 08/27/13 Boston
Companion Diagnostics for Cancer Drugs Advancing Personalized Medicine 01/31/13 Boston
Aura Adds $4.5M, Syndax To Present Breast Cancer Results at ASCO, PKE Buys Caliper, & More Boston-Area Life Sciences News 09/09/11 Boston
Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News 07/08/11 Boston
Syndax Moves Closer to Pivotal Trials of Selective Lung Cancer Treatment 07/05/11 Boston
DARPA Backs Pulmatrix’s Lung Treatment, Adimab Scores More Pharma Partners, Semprus Secures $18M, & More Boston-Area Life Sciences News 12/17/10 Boston
Syndax Pharma Study Offers Clues that Lung Cancer Treatment Could Benefit Subset of Patients 12/10/10 Boston
Former Sirtris Execs Sell Resveratrol Via New Nonprofit, Dicerna Closes $25M Deal, ViThera Combats Gut Disease With Engineered Bacteria, & More Boston-Area Life Sciences News 08/13/10 Boston
Page 1 of 2 next page »